Save
The Effect Of Fasting Ramadan On the Efficacy And Safety Of Oral Anticoagulants
ISTH Academy, Fakhr Alayoubi, 264343
Assessing the impact of switching to the tobacco heating system on cardiovascular events: translating basic science into clinical benefit
ISTH Academy, Calin Pater, 264344
The mortality outcomes and survival patterns of myeloproliferative neoplasm registry in Malaysia
ISTH Academy, Yee Yap, 264345
Audit of the use of the GEKO device on an Acute Stroke Unit (ASU)
ISTH Academy, Sue Rhodes, 264366
Immunohistologic analysis of von Willebrand factor in thrombi retrieved from patients with acute ischemic stroke
ISTH Academy, Hisao Shimizu, 264367
Rheological and Hemostatic Aspects of Venous Thromboembolism in Patients with Severe Stroke
ISTH Academy, Kostiantyn Stepanchenko, 264368
The traceability of commercial plasma calibrators to the plasma international standard for factor IX
ISTH Academy, Helen Wilmot, 264383
Heterogeneity in levels of FVIII and VWF expression in subpopulations of human endothelial cells
ISTH Academy, David Lillicrap, 264384
Mapping of coagulation factor IX binding site on Collagen Toolkits II, III and XIII
ISTH Academy, Samir Hamaia, 264385
Coagulation imbalance in patients with Acute-on-Chronic Liver Failure (ACLF) measured by global and classical coagulation tests
ISTH Academy, Elena Campello, 264400
ADAMTS-13 and Von Willebrand Factor involved in Portal Vein Thrombosis development in cirrhotic patients
ISTH Academy, Monica Sacco, 264401
Coagulation status of critically ill patients with liver disease assessed using a novel thrombin generation analyser
ISTH Academy, Gael B Morrow, 264402
polymorphisms in non-coding regions of the protein c gene regulate plasmatic protein c levels
ISTH Academy, Julia Oto, 264418
Competitive binding, and accounting for procoagulant platelets, significantly change thrombin profiles in in vitro coagulation
ISTH Academy, Mohan Anand, 264419
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
ISTH Academy, Björn Dahlbäck, 264420
Abstract 1: Assessment of Validated Risk Assessment Models and a Biomarker Ubiquitous in Routine Clinical Care to Identify Hospitalized Medical Patients at Risk for 90-day Post-discharge Venous Thromboembolism
ISTH Academy, Scott Woller, 264438
Laboratory marker of hypercoagulability: a ratio combining thrombin-generation with fibrin-clot-formation
ISTH Academy, Debora Bertaggia-Calderara, 264439
Antiphospholipid antibodies and thrombosis in BCR-ABL negative myeloproliferative neoplasms
ISTH Academy, Rolandas Gerbutavičius, 264440
Abstract 2: Comparative Benefit of Adding a Biomarker Ubiquitously Available in Clinical Care to Validated Risk Assessment Models for the Identification of Hospitalized Medical Patients at Risk for 90-day Hospital-associated Venous Thromboembolism
ISTH Academy, Scott Stevens, 264456
Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: a cost-effectiveness analysis
ISTH Academy, Marc Blondon, 264457
Relationship of type 1 Plasminogen Activator Inhibitor with Glycosilated Hemoglobin levels in type 2 Diabetic Patients - Guillermo Almenara National Hospital - ESSALUD - Lima, 2016
ISTH Academy, Haydee Iparraguirre Lopez, 264458
Evaluation of hemostasis in patients with Alzheimer´s disease and frontotemporal dementia by thrombin generation test
ISTH Academy, Luci Dusse, 264459
Evaluation of thrombin generation in patients with dermatomyositis and polymyositis
ISTH Academy, Jerzy Dropinski, 264472
Factors Associated with a Negative D-dimer Test in Patients Diagnosed with Acute Symptomatic Pulmonary Embolism
ISTH Academy, Stefano Barco, 264474
The FDP/D-dimer ratio and LDH/Hb ratio are useful to distinguish between TTP and DIC
ISTH Academy, Nobushiro Nishimura, 264475
Auto- or Allo-Antibodies to hemostasis Proteins and their Patho-Physiological Effects
ISTH Academy, Jean Amiral, 264476
Performance evaluation of a new fully automated thrombin generation instrument for the measurement of TGA in Haemophilia samples
ISTH Academy, Nikolaus Bernhard Binder, 264489
Use of chromogenic Factor VIII activity determination in Haemophilia A plasma of patients under emicizumab treatment
ISTH Academy, Nikolaus Bernhard Binder, 264490
Development of a point-of-care diagnostic test to identify and differentiate between factor-deficient and autoantibody-induced hemophilia A, B and C
ISTH Academy, Galit Frydman, 264491
Variation in one-stage coagulation reagents in FIX Extended Half-life product measurements in External Quality Control Assessment programs
ISTH Academy, Moniek De Maat, 264492
Correlation of bleeding scores with Flowcytometry Platelet Aggregation test in patients with a suspected bleeding disorder
ISTH Academy, Jasmina Ahluwalia, 264507
Exome sequence findings and bleeding manifestations for uncharacterized platelet function disorders with impaired aggregation responses and/or non-syndromic dense granule deficiency: Results from the Hamilton Platelet Disorder Study
ISTH Academy, Catherine Hayward, 264508
Microscopic Platelet Adhesion Assessment - An Approach towards Standardization
ISTH Academy, Johanna Charlotte Clauser, 264509
Effects of clopidogrel versus ticagrelor on platelet function in patients undergoing percutaneous coronary intervention: assessed by light transmission aggregometry, vasodilator-stimulated phosphoprotein assay and mean platelet volume
ISTH Academy, Yang Zhang, 264510
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis
ISTH Academy, Joachim C Mertens, 264527
Features of the action of a new synthetic peptide of the melanocortin family on fibrinolysis
ISTH Academy, Tatyana Shubina, 264528
Towards the structure-function analysis of factor VII activating protease (FSAP)
ISTH Academy, Dipankar Manna, 264529
Determinants of plasma fibrin clot lysis using three different assays in patients with aortic stenosis
ISTH Academy, Jakub Siudut, 264544
Elucidation of the molecular mechanisms of nanobodies that affect plasminogen activator inhibitor 1 (PAI-1) activity highlights their versatility in modulating various stages in the PAI-1/plasminogen activator (PA) interaction
ISTH Academy, Paul Declerck, 264546
Single institution experience of thrombolysis for acute pulmonary embolism in a retrospective cohort of Australian patients
ISTH Academy, Ming Sheng Lim, 264548
Acquired Hemophilia A (AHA) : A Single Centre Malaysian Outlook
ISTH Academy, Christopher, Chin Keong Liam, 264564
Validation of hemostatic impairment induced by hydroxyethyl starch (HES) due to influence on vascular endothelium
ISTH Academy, Ryu Azumaguchi, 264565
New elements involved in the skin haemorrhage induced by snake venom metalloproteinases: proteoglycans and platelet-derived growth factor receptor
ISTH Academy, Solange M T Serrano, 264566
THE EVALUATION OF PAROXISMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WHO UNDERWENT ECULIZUMAB THERAPY
ISTH Academy, Fahri Şahin, 264581
Reported Presentation, Treatment, Mutation Analysis and Outcome of Two Children with Atypical Hemolytic Uremic Syndrome
ISTH Academy, Pongpak Pongphitcha, 264582
Effect of complement activation in septic disseminated intravascular coagulation
ISTH Academy, Tomohiro Abe, 264583
Anti-FVIII IgG1 antibodies in patients with hemophilia A during factor VIII replacement: results from the HEMFIL Study
ISTH Academy, Letícia Lemos Jardim, 264598
Evaluation of the analytical performances of a new emicizumab assay on STA-R & STA Compact Max
ISTH Academy, Matthieu Bourdin, 264599
Long-term outcomes after switch from on-demand treatment to prophylaxis with rFVIIIFc: longitudinal subgroup analysis of the A-LONG and ASPIRE study population
ISTH Academy, Maria Teresa Roman, 264600
Comparison of Pharmacokinetic Outputs from a Non-compartmental Analysis and myPKFiT™ in Taiwanese Hemophilia Patients
ISTH Academy, Shin-Nan Cheng, 264614
Survey of Haemophilia Care in Nigeria: Physicians response from 35 centres in 20 states of the Federation
ISTH Academy, Wuraola A. Shokunbi, 264615
HLA-DR Processing and Presentation of Two Peptide Antigen Clusters in PEG-BDD-FVIII (BAY94-9027) by Dendritic Cells is Impaired Resulting in Defective T-helper Response In Vitro
ISTH Academy, Pedro Paz, 264616
Major impact of the World Federation of Hemophilia humanitarian aid program on initiation of primary prophylaxis with extended half-life Factor VIII and IX in Côte d’Ivoire
ISTH Academy, Cedric Hermans, 264631
Transition from standard half-life to extended half-life products in patients with haemophilia A and B: a single center experience
ISTH Academy, Marissa Traets, 264632
THE EXPERIENCE OF MAJOR ORTHOPEDIC SURGERIES IN PATIENTS WITH SEVERE HEMOPHILIA
ISTH Academy, Alphan Kupesiz, 264633
Results from a Prospective, Multicenter, Dose Escalating, Prophylaxis Study in Young Boys with Severe Haemophilia A in China: The China Haemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)
ISTH Academy, Runhui Wu, 264647
Social Participation of Patients with Haemophilia: Preliminary Results from the Nationwide ‘Haemophilia in the Netherlands 6 study’
ISTH Academy, Erna Van Balen, 264648
Immune Tolerance Induction with Simoctocog Alfa in Nine Patients with Severe Haemophilia A and FVIII Inhibitors
ISTH Academy, Ri J Liesner, 264649
Reversal of anticoagulation in patients on rivaroxaban or apixaban (DOAC) with major bleeding episodes (MBE) with 4 factor prothrombin complex concentrates (PCC): a multicentre retrospective study
ISTH Academy, Christian Gallardo, 264666
Injectable biotinylated platelets for transfusion in clinical trials
ISTH Academy, Arnaud Dupuis, 264668
Thromboelastometry in patients with positive lupus anticoagulant. Is there any potential impact on haemostasis monitoring during Cardiovascular Surgery?
ISTH Academy, Marina Lopez, 264669
Direct Xa-inhibitor reversal with a 4-factor prothrombin complex concentrate prior to urgent surgery
ISTH Academy, Paul P Dobesh, 264683
Comparative Studies on the anticoagulant activities of orally active anti-Xa and anti-IIa agents in whole blood and retrieved plasma and their neutralization by FEIBA
ISTH Academy, Rithik Raina, 264684
Idarucizumab for dabigatran reversal in clinical practice: a French retrospective study of 41 cases
ISTH Academy, Nicolas Gendron, 264685
HIGH PLASMATIC LEVELS OF CELL FREE DNA ARE ASSOCIATED WITH POOR PROGNOSIS IN SEPTIC PATIENTS
ISTH Academy, Mauro Moiana, 264701
Venous Thromboembolism Trends and Impact in Patients with Rheumatoid Arthritis: Analysis of The National Inpatient Sample Database 2003-2014
ISTH Academy, Guillermo Tafur, 264702
Activation-specific small binding proteins targeted towards the integrin Mac-1 - Measuring inflammation by means of monocyte activation in STEMI- and ECMO-patients
ISTH Academy, Patrick Siegel, 264703
The Role of Serotonin on Haematopoiesis and Proplatelet Formation
ISTH Academy, Mo Yang, 264717
Buffy coat, a potential source of hematopoietic stem cells for in vitro platelet production
ISTH Academy, Irene Marini, 264718
Aerobic glycolysis and the consequent flux through pentose phosphate pathway fuel platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents
ISTH Academy, Paresh Kulkarni, 264719
Moderate decreased platelet counts but high platelet activation defects alter hemostasis and arterial thrombosis after partial hepatectomy in mice
ISTH Academy, Lili Donner, 264735
Simultaneous secretion of spatially-separated dense granules in single platelets upon their activation with ADP and thrombin
ISTH Academy, Taisia Shepeliuk, 264736
Continuous flow cytometry assay of platelet signalling and function: a tool for characterization of inherited and acquired platelet disorders
ISTH Academy, Alexey Martyanov, 264737
ABT-737 triggers caspase-dependent inhibition of platelet procoagulant extracellular vesicle release during apoptosis and secondary necrosis in vitro
ISTH Academy, Matthew Harper, 264751
Platelets express a truncated form of TrkB involved in BDNF signaling
ISTH Academy, Imane Boukhatem, 264752
Study on the mechanism of SCUBE1 in regulating platelet function
ISTH Academy, Xianghui Zhou, 264753
Adult onset hereditary thrombotic thrombocytopenic purpura (TTP) with a novel ADAMTS13 mutation
ISTH Academy, Julian Matias Freue, 264770
Cost of Illness (COI) of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) in the United States
ISTH Academy, Abiola Oladapo, 264771
Design of the First Clinical Study of Recombinant ADAMTS13 for the Acute Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
ISTH Academy, Christopher Hibbard, 264772
Severe hemolytic jaundice with thrombocytopenia at birth in congenital TTP is caused by physiological constriction of ductus arteriosus
ISTH Academy, Kazuya Sakai, 264786
Non-severe Congenital Deficiency of ADAMTS13 Presenting as Thrombotic Microangiopathy during Pregnancy
ISTH Academy, Miguel Escobar, 264787
Complement Abnormalities in a Cohort of Argentinean Patients with Atypical Hemolytic Uremic Syndrome
ISTH Academy, Celia Dos Santos, 264788
Potency Adjusted Bovine Heparin is Comparable to Porcine Heparin in Patients Undergoing Open Heart Surgery
ISTH Academy, Ahmed Kouta, 264803
Enoxaparins Derived from Ovine (Sheep) Tissues are Biosimilar to Branded Enoxaparin of Porcine (Pig) Origin
ISTH Academy, Tishya Indran, 264804
Heparins Derived from Ovine (Sheep) Mucosa are Interchangeable to their Porcine (Pig) Counterparts
ISTH Academy, Tishya Indran, 264805
Decreased plasma fibrinolytic potential in venous thrombosis patients using CloFAL assay and the association with post-thrombotic syndrome and residual thrombus
ISTH Academy, Melissa Quintero, 264820
Virchow’s triad: is it applicable to thrombosis of mesenteric vessels?
ISTH Academy, Bushra Moiz, 264821
Utility of the DASH score after unprovoked venous thromboembolism: single centre study and long-term patient outcomes
ISTH Academy, Will Thomas, 264822
Birth of a coagulation clinic and its burden at the department of clinical hematology, Yangon General Hospital, Myanmar
ISTH Academy, SEIN WIN, 264837
Outcomes of NOAC-treated patients with depression - results from the Dresden NOAC Registry (NCT01588119)
ISTH Academy, Jan Beyer-Westendorf, 264838
The role of anxiety and depression in the pathogenesis of thromboembolic events currently classified as unprovoked
ISTH Academy, Silvia Hoirisch-Clapauch, 264839
Dual antiplatelet therapy on Veno-Arterial ECMO: to bleed or not to bleed?
ISTH Academy, Christophe Vandenbriele, 264854
Non hepatic causes of Adult Splanchnic Vein Thrombosis. A monocentric report of 24 cases
ISTH Academy, Zoubida Tazi Mezalek, 264855
Interim analysis - Safety and efficacy of rivaroxaban in a patient population with short bowel syndrome; a prospective observational cohort study
ISTH Academy, Roisin Bavalia, 264856
Predicting recurrence after unprovoked venous thromboembolism: Comparison of DASH, HERDOO2, and Vienna score in the same cohort of patients
ISTH Academy, Stephany Cares Huber, 264871
Antithrombin and D-dimer in predicting pregnancy complications in the 3rd trimester of pregnancy
ISTH Academy, Ning Tang, 264874
Assessment of the Knowledge about Venous Thromboembolism (VTE) on Pregnant Women Attending Kigali Referral Hospitals
ISTH Academy, Christine Ashimwe, 264877
Systemic Soluble Mediators in HELLP Syndrome Case Report
ISTH Academy, Luci Dusse, 264895
The Challenges of Managing Severe Haemophilia A and Pregnancy in Same Sex Couples
ISTH Academy, Bella Madan, 264896
Pregnancy, childbirth and neonatal outcomes in women with inherited bleeding disorders
ISTH Academy, Lisa Clarke, 264897

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings